ApplicationSmall molecule compounds to potentiate most common type of CFTR mutation in cystic fibrosis patients.Key BenefitsPotentiates ΔF508-hCFTR mutation, addressing more than 60 percent of CF patients. Market SummaryCystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein.....
[Detail]
This invention provides compositionsand methods to regulate gene expression invivo by placing trans-actingsmall RNAs, called Small TranscriptionActivating/Attenuating RNAs (STARs),at upstream of a gene of interest.
[Detail]
The estimated power savings for idle computers running “sleep-server” is greater than 90 percent.
[Detail]
| |< <- | [3051] [3052] [3053] [3054] [3055] [3056] [3057] [3058] [3059] [3060] [3061] | -> >| |
